A Study Evaluating the Effects of GLPG3970 Given as an Oral Treatment for 6 Weeks in Adults With Moderately to Severely Active Rheumatoid Arthritis and an Inadequate Response to Methotrexate
Clinical trial NCT04577781 · COMPLETED
Trial details
- NCT number
- NCT04577781
- Sponsor
- Lakefront Biotherapeutics NV
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-12
- Primary completion
- 2021-03-26
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.